Business Exposures
Activism
Animal Testing
Artificial Intelligence
Boeing 737
Brexit
Cannabis
Censorship
Climate
Coal
COVID-19
Criminal
Death
Debt Markets
Derivatives
Diversity
Economy
Electric Vehicles
Electricity Generation
Ethanol
Financial
Firearms
Fossil Fuels
Glyphosate
Harassement
Immigration
Information Security
Intellectual Property
Interest Rates
Labor
Layoff
Lead
Legal
Palm Oil
Pension
Political
Product Safety
Regulatory
Religion
Securities Market
Supply Chain
Tariff
Textiles
US Equities
< Previous
1
2
3
4
5
6
7
8
9
...
99
100
Next >
DEA Vs. Biden, FDA & Health Agency Over Cannabis Rescheduling: What's Up With That?
June 11, 2024
Via
Benzinga
Topics
Cannabis
Exposures
Cannabis
Product Safety
Eli Lilly's Donanemab Gains Favorable FDA Advisory Verdict, Boosting Stock Potential, Says BofA Analyst
June 11, 2024
Via
Benzinga
Exposures
Product Safety
Tickers
BIIB
ESAIY
LLY
InvestorNewsBreaks – Cybin Inc. (NYSE American: CYBN) (Cboe CA: CYBN) Announces Strategic Appointment of Dr. Atul Mahableshwarkar
June 11, 2024
Via
Investor Brand Network
Exposures
Product Safety
Tickers
CYBN
Healthcare Innovation Leader Suzy Engwall Joins Actuated Medical's Board of Directors
June 11, 2024
Via
PRLog
Topics
Intellectual Property
Exposures
Intellectual Property
Product Safety
Surging Biotech M&A Reaffirms Massive Opportunity In Rare Disease Drug Development (CRDL,JAZZ, NVO, AZN, SNY)
June 11, 2024
Via
AB Newswire
Exposures
Product Safety
Psychedelic Stocks Fall as Advisory Panel Tells FDA Not to Approve MDMA
June 11, 2024
Via
Investor Brand Network
Exposures
Product Safety
Kia Recalls Over 460K Telluride SUVs In US Due To Fire Risk From Overheating Seat Motors
June 07, 2024
Via
Benzinga
Topics
Product Recall
Exposures
Legal
Product Safety
Eli Lilly Drags Alzheimer's Stocks Prothena, Eisai Lower Despite FDA Win
June 11, 2024
Via
Investor's Business Daily
Exposures
Product Safety
Tickers
BIIB
ESAIY
LLY
PRTA
Eli Lilly Stock Hits New 52-Week High as FDA Panel Recommends Alzheimer’s Drug
June 11, 2024
Via
InvestorPlace
Exposures
Product Safety
Tickers
LLY
NOC
Tonix Pharmaceuticals Nears Market Entry with Tonmya for Fibromyalgia Management
June 11, 2024
Via
News Direct
Topics
Economy
Exposures
Interest Rates
Product Safety
Tonix Pharmaceuticals Nears Market Entry with Tonmya for Fibromyalgia Management
June 11, 2024
Via
TheNewswire.com
Topics
Economy
Exposures
Interest Rates
Product Safety
FDA Fast-Tracks Ipsen And Genfit's New Liver Disease Treatment, Iqirvo
June 11, 2024
Via
Benzinga
Exposures
Product Safety
Tickers
GNFT
IPSEY
Global Multiple Sclerosis Drugs Market Size Projected to Reach $38 Billion By 2032 as Demand on R&D for Developing Innovative Drugs Rises
June 11, 2024
Via
FinancialNewsMedia
Exposures
Product Safety
Tickers
BIIB
LLY
RHHBY
TGTX
Why Is Eli Lilly Stock Trading Higher Premarket Tuesday?
June 11, 2024
Via
Benzinga
Exposures
Product Safety
Tickers
BIIB
ESALF
LLY
3 Vaccine Stocks to Buy as the FDA Cracks Down on New Variants
June 11, 2024
Via
InvestorPlace
Exposures
Product Safety
Tickers
MRNA
NVAX
PFE
Surging Biotech M&A Reaffirms Massive Opportunity In Rare Disease Drug Development
June 11, 2024
Via
TheNewswire.com
Exposures
Product Safety
Surging Biotech M&A Reaffirms Massive Opportunity In Rare Disease Drug Development
June 11, 2024
Via
News Direct
Exposures
Product Safety
Stellantis' Chrysler Recalls Certain Dodge & Ram Trucks Due To Software Glitch
June 10, 2024
Via
Benzinga
Topics
Product Recall
Exposures
Legal
Product Safety
Tickers
STLA
Eli Lilly Rises Again, As FDA Panel Mulls Biogen-Rivaling Alzheimer's Drug
June 10, 2024
Via
Investor's Business Daily
Exposures
Product Safety
Tickers
BIIB
ESAIY
LLY
Volvo Recalls 72K New Electric Luxury SUV EX30 Over Software Glitch
June 10, 2024
Via
Benzinga
Topics
Product Recall
Exposures
Legal
Product Safety
Psychedelics Stocks Are Falling After a Shocking Vote at the FDA. Here's What You Need to Know.
June 10, 2024
Via
The Motley Fool
Exposures
Product Safety
Tickers
CMPS
Abbott Snags U.S. Clearance To Enter The Obesity Arena, Rivaling Dexcom
June 10, 2024
Via
Investor's Business Daily
Exposures
Product Safety
Tickers
ABT
DXCM
LLY
NVO
Geron Corporation: FDA Approval Fuels Stock Price Surge
June 07, 2024
Via
MarketBeat
Exposures
Product Safety
Tickers
GERN
Moderna Seeks FDA Approval For Updated COVID-19 Shot For Upcoming Season
June 07, 2024
Via
Benzinga
Exposures
COVID-19
Product Safety
Tickers
BNTX
MRNA
NVAX
PFE
Why Biomea Fusion (BMEA) Stock Is Down 60%
June 07, 2024
Via
Benzinga
Exposures
Product Safety
Tickers
BMEA
FDA Reverses Juul Ban. What Comes Next?
June 07, 2024
Via
InvestorPlace
Exposures
Product Safety
Tickers
GERN
GME
Why Is Geron (GERN) Stock Up 18% Today?
June 07, 2024
Via
InvestorPlace
Exposures
Product Safety
Tickers
AAPL
GERN
NVDA
FDA Approves Geron's First Commercial Drug, Competes With Bristol Myers Squibb's Blood Cancer Drug
June 07, 2024
Via
Benzinga
Exposures
Product Safety
Tickers
BMY
GERN
Biomea Fusion Crashes 65% After FDA Puts Diabetes Treatment Studies On Hold
June 07, 2024
Via
Investor's Business Daily
Exposures
Product Safety
Tickers
BMEA
Theriva Biologics Receives Fast Track Designation From FDA For VCN-01 For Treating Metastatic Pancreatic Cancer
June 07, 2024
Via
News Direct
Exposures
Product Safety
Tickers
TOVX
< Previous
1
2
3
4
5
6
7
8
9
...
99
100
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.